Christine Charette, SVP Strategic Finance, OBIO offers her insights into the premiere conference for MedTech companies.
Health Economics in the Medical Device Space
Thoughts from OBIO's own VP of Strategic Finance, Christine Charette, summarizing the topics relevant to startups at the 2016 AdvaMed Conference.
For the PDF article click here
RESI Conference and Digital Medicine Connect at Biopharm America: Part 2
Christine Charette, SVP Strategic Finance, OBIO shares her advice on navigating the Health Science Investor in Part 2 of the Combined Conference Insights on RESI Boston & Digital Medicine Connect at BioPharm America September 13,14,15 2016
For the full PDF of the article click here
RESI conference and Digital medicine connect at Biopharm America
Christine Charette, SVP Strategic Finance, OBIO offers her perspective on the RESI conference and BioPharm America.
For a PDF of the full article, click here
Beyond Novelty: Adopting & Diffusing Innovation in the Supply Chain
Health Science Insider™ (OBIO Strategic Review: July 2016)
2016 has already been a productive year for OBIO as we push forward on our advocacy efforts, expand our Health Science networks and partnerships and continue to provide access to capital for Ontario Health Science companies in order for them to reach the next level.
Gail Garland, CEO
OBIO
For the full strategic review, click here
OBIO® Report Featured in Media Planet's Industry and Business Magazine
The article titled "From Opportunities To ROI – Adopting Innovation In Canada" focusses on the key recommendations of the OBIO report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy.”
Click here for the full article
OBIO® Report: Canadian health industry competitive but doesn't stand out
OBIO is a not-for-profit organization committed to the development of an integrated health innovation economy for the province. Its report, How Canada Should be Engaging in a $9 Trillion Dollar Health Economy, was based on surveys and interviews with 125 CEOs of health science companies around the country. It makes recommendations aimed to ensure Canadians get the economic and patient benefits from being competitive in the global health market.
OBIO Launches Report in the Nation’s Capital
OBIO comments on Canada's Innovation Agenda
Tuesday in a joint announcement the Minister of Innovation Science and Economic Development, Minister of Science, and the Minister of Small Business and Tourism unveiled 6 action areas to build an innovative Canada.
For OBIO's comments on report, click here.
PATHS TO THE FUTURE: HOW CANADA SHOULD BE ENGAGING IN A $9 TRILLION DOLLAR HEALTH ECONOMY VS. THE CANADIAN INNOVATION AGENDA
On Tuesday June 16, 2016 the first steps began towards the development of a Canadian National Inclusive Innovation Agenda. In a joint announcement the Minister of Innovation Science and Economic Development, Minister of Science, and the Minister of Small Business and Tourism unveiled 6 action areas to build an innovative Canada.
How Canada Should be Engaging in a $9 Trillion Dollar Health Economy
There are compelling reasons for a strong, Canadian healthcare industry. Canada has opportunities but there are barriers to success. This report presents industry’s solutions.
Federal Budget Misses Opportunity to Scale and Grow Health Science Companies
The 2016 Federal Liberal budget contains funding to support a much needed Innovation Agenda and promises to build globally competitive companies. At the same time the majority of this funding is directed to incubators and accelerators, granting councils and public institutions to support basic research. In order to compete in the $9 trillion global health science economy, Canada needs to devote financial resources to health science companies at the next stage of development by investing in scale up, job creation and revenue generation.
Click here to read the article online
OBIO Strategic Review: December 2015
An organization's ability to learn, and translate that learning into action rapidly, is the ultimate competitive advantage.
Jack Welch
As we come to the end of 2015, OBIO is proud of a year that has been characterized by recognition and support from our partners and sponsors, new learnings from the extensive feedback we received during our industry consultations and a very busy schedule as we delivered on programming and advocacy work.
Click here to read the article online